Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment

Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection

(2022) Jia-Fong Jhang et al.   International Neurourology Journal

Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome—A Comparative Study of Different Injection Number, Additives and Concentrations

(2022) Yuan-Hong Jiang et al.   Frontiers in Pharmacology

Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma

(2022) Yu-Khun Lee et al.   Biomedicines

Clinical guidelines for interstitial cystitis/bladder pain syndrome

(2020) Yukio Homma et al.   INTERNATIONAL JOURNAL OF UROLOGY

Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder: A Systematic Review

(2020) Mohammad Abrar et al.   European Urology Focus

Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis

(2020) Yuan-Hong Jiang et al.   Scientific Reports

Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial

(2018) Jia-Fong Jhang et al.   NEUROUROLOGY AND URODYNAMICS

Cytokine, chemokine, and growth factor profile of platelet-rich plasma

(2016) F. Mussano et al.   PLATELETS

Platelet-rich plasma reduces skin flap inflammatory cells infiltration and improves survival rates through induction of angiogenesis: An experiment in rabbits

(2016) Biao Wang et al.   Journal of Plastic Surgery and Hand Surgery

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

(2016) Yuh-Chen Kuo et al.   Toxins

Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment

(2015) Philip M. Hanno et al.   JOURNAL OF UROLOGY

Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial

(2015) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome

(2015) Cheng-Ling Lee et al.   Toxins

Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors

(2013) Paola Amable et al.   Stem Cell Research & Therapy

Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome

(2012) Jia-Heng Shie et al.   BJU INTERNATIONAL

Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder

(2012) Youko Ikeda et al.   EUROPEAN UROLOGY

Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup

(2008) Antonella Giannantoni et al.   JOURNAL OF UROLOGY